Histone acetyltransferase 3D structures
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | *Histone acetyltransferase; Human domains – DPF 194-323; HAT 170-458; catalytic 497-662; bromodomain 729-837; | + | *Histone acetyltransferase; Human domains – WH 100-182; DPF 194-323; HAT 170-458; catalytic 497-662; bromodomain 729-837; |
**[[1f68]] – hHAT bromodomain (mutant) – human – NMR | **[[1f68]] – hHAT bromodomain (mutant) – human – NMR | ||
Line 26: | Line 26: | ||
**[[2ln0]] - hHAT KAT6A<br /> | **[[2ln0]] - hHAT KAT6A<br /> | ||
**[[4ljn]] - hHAT KAT6A double PHD finger<br /> | **[[4ljn]] - hHAT KAT6A double PHD finger<br /> | ||
+ | **[[8e4v]] - hHAT KAT6B WH domain - NMR<br /> | ||
**[[5wci]] - hHAT KAT8 HAT domain <br /> | **[[5wci]] - hHAT KAT8 HAT domain <br /> | ||
**[[7cmr]] - hHAT KAT8 1-458 <br /> | **[[7cmr]] - hHAT KAT8 1-458 <br /> | ||
Line 59: | Line 60: | ||
**[[4dnc]] – hHAT KAT8 HAT domain + male-specific lethal 1 homolog<br /> | **[[4dnc]] – hHAT KAT8 HAT domain + male-specific lethal 1 homolog<br /> | ||
**[[3v43]], [[4lk9]], [[4lka]], [[4llb]], [[5b75]], [[5b76]], [[5b77]], [[5b78]], [[6lsb]] - hHAT KAT6A + H3.1 peptide<br /> | **[[3v43]], [[4lk9]], [[4lka]], [[4llb]], [[5b75]], [[5b76]], [[5b77]], [[5b78]], [[6lsb]] - hHAT KAT6A + H3.1 peptide<br /> | ||
+ | **[[7y43]], [[8h7a]] - hHAT KAT6A + DNA<br /> | ||
**[[5u2j]], [[6oie]] - hHAT KAT6B + H3K14BU peptide<br /> | **[[5u2j]], [[6oie]] - hHAT KAT6B + H3K14BU peptide<br /> | ||
**[[5gk9]], [[6maj]], [[6mak]], [[7d0o]] - hHAT KAT7 + BRD1<br /> | **[[5gk9]], [[6maj]], [[6mak]], [[7d0o]] - hHAT KAT7 + BRD1<br /> | ||
Line 66: | Line 68: | ||
**[[5h86]], [[6ba4]] - hHAT KAT8 HAT domain + acetyl CoA<br /> | **[[5h86]], [[6ba4]] - hHAT KAT8 HAT domain + acetyl CoA<br /> | ||
**[[7kpy]] - hHAT 617-732 + inhibitor <br /> | **[[7kpy]] - hHAT 617-732 + inhibitor <br /> | ||
+ | **[[7qgs]] - hHAT 330-440 + MRG-1<br /> | ||
**[[5ml0]] - mHAT KAT2B bromodomain + inhibitor<br /> | **[[5ml0]] - mHAT KAT2B bromodomain + inhibitor<br /> | ||
**[[1bob]] – yHAT 1 + acetyl-CoA | **[[1bob]] – yHAT 1 + acetyl-CoA | ||
Line 92: | Line 95: | ||
**[[7d0p]], [[7d0q]], [[7d0r]], [[7d0s]] - hHAT KAT7 + BRD1 + CoA derivative<br /> | **[[7d0p]], [[7d0q]], [[7d0r]], [[7d0s]] - hHAT KAT7 + BRD1 + CoA derivative<br /> | ||
**[[3q33]] – yHAT RTT109 + vacuolar protein sorting-associated protein 75 + histone H3 peptide<br /> | **[[3q33]] – yHAT RTT109 + vacuolar protein sorting-associated protein 75 + histone H3 peptide<br /> | ||
+ | **[[7xay]] – yHAT1 + HAT2 + ASF1 + histone H3 + histone H4 <br /> | ||
**[[6o22]] - yHAT RTT109 + vacuolar protein sorting-associated protein 75 + ASF1 + histone H3.2 + histone H4 – NMR<br /> | **[[6o22]] - yHAT RTT109 + vacuolar protein sorting-associated protein 75 + ASF1 + histone H3.2 + histone H4 – NMR<br /> | ||
**[[4psx]] - yHAT B + H3 peptide + H4 peptide<br /> | **[[4psx]] - yHAT B + H3 peptide + H4 peptide<br /> | ||
Line 103: | Line 107: | ||
**[[3i3j]] – hHAT P300 bromodomain <br /> | **[[3i3j]] – hHAT P300 bromodomain <br /> | ||
+ | **[[7uge]], [[7ugi]], [[7ugl]] - hHAT P300 bromodomain + inhibitor <br /> | ||
**[[3io2]] – hHAT P300 TAZ2 domain <br /> | **[[3io2]] – hHAT P300 TAZ2 domain <br /> | ||
+ | **[[6fgn]], [[6fgs]] - hHAT TAZ2 domain - NMR<br /> | ||
+ | **[[2mzd]] - hHAT TAZ2 domain (mutant) + p53 peptide - NMR<br /> | ||
**[[4bhw]] - hHAT P300 core (mutant)<br /> | **[[4bhw]] - hHAT P300 core (mutant)<br /> | ||
**[[6k4n]] - hHAT P300 bromodomain+acetyltransferase domains – Cryo EM<br /> | **[[6k4n]] - hHAT P300 bromodomain+acetyltransferase domains – Cryo EM<br /> | ||
Line 116: | Line 123: | ||
**[[3biy]] – hHAT P300 acetyltransferase domain + lysine CoA derivative<br /> | **[[3biy]] – hHAT P300 acetyltransferase domain + lysine CoA derivative<br /> | ||
**[[5kj2]], [[7lje]] - hHAT P300 acetyltransferase domain + inhibitor<br /> | **[[5kj2]], [[7lje]] - hHAT P300 acetyltransferase domain + inhibitor<br /> | ||
- | **[[6pf1]], [[6v8b]], [[6v8k]], [[6v8n]], [[6v90]] - hHAT P300 acetyltransferase domain (mutant) + inhibitor<br /> | + | **[[6pf1]], [[6v8b]], [[6v8k]], [[6v8n]], [[6v90]], [[7ss8]], [[7ssk]], [[7szq]], [[7vhy]], [[7vhz]], [[7vi0]], [[8gzc]] - hHAT P300 acetyltransferase domain (mutant) + inhibitor<br /> |
**[[6pgu]] - hHAT P300 acetyltransferase domain (mutant) + inhibitor + CoA<br /> | **[[6pgu]] - hHAT P300 acetyltransferase domain (mutant) + inhibitor + CoA<br /> | ||
**[[6gyr]] - hHAT P300 core+acetyltransferase domains + lysine CoA derivative<br /> | **[[6gyr]] - hHAT P300 core+acetyltransferase domains + lysine CoA derivative<br /> | ||
Line 122: | Line 129: | ||
**[[5bt3]], [[5nu5]], [[5lpk]], [[5lpm]] - hHAT P300 bromodomain + inhibitor<br /> | **[[5bt3]], [[5nu5]], [[5lpk]], [[5lpm]] - hHAT P300 bromodomain + inhibitor<br /> | ||
**[[6gyt]] - hHAT P300 bromodomain + histone H4 peptide<br /> | **[[6gyt]] - hHAT P300 bromodomain + histone H4 peptide<br /> | ||
+ | **[[7w9v]], [[8hag]], [[8hah]], [[8hai]], [[8haj]], [[8hak]] - hHAT P300 1098-1836 + nucleosome – Cryo EM<br /> | ||
**[[3p57]] - hHAT P300 TAZ2 domain + myocyte-specific enhancer factor 2A + DNA | **[[3p57]] - hHAT P300 TAZ2 domain + myocyte-specific enhancer factor 2A + DNA | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 07:49, 21 May 2023
3D Structures of histone acetyltransferase
Updated on 21-May-2023